User profiles for Laurent Dercle
Laurent DercleNewYork-Presbyterian Hospital - Columbia University Irving Medical Center Verified email at cumc.columbia.edu Cited by 5913 |
Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1/PD-L1
Purpose: While immune checkpoint inhibitors are disrupting the management of patients with
cancer, anecdotal occurrences of rapid progression (ie, hyperprogressive disease or HPD) …
cancer, anecdotal occurrences of rapid progression (ie, hyperprogressive disease or HPD) …
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective …
Background Because responses of patients with cancer to immunotherapy can vary in success,
innovative predictors of response to treatment are urgently needed to improve treatment …
innovative predictors of response to treatment are urgently needed to improve treatment …
[HTML][HTML] Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
Medical image processing and analysis (also known as Radiomics) is a rapidly growing
discipline that maps digital medical images into quantitative data, with the end goal of …
discipline that maps digital medical images into quantitative data, with the end goal of …
Identification of non–small cell lung cancer sensitive to systemic cancer therapies using radiomics
Purpose: Using standard-of-care CT images obtained from patients with a diagnosis of non–small
cell lung cancer (NSCLC), we defined radiomics signatures predicting the sensitivity of …
cell lung cancer (NSCLC), we defined radiomics signatures predicting the sensitivity of …
Toward generalizability in the deployment of artificial intelligence in radiology: role of computation stress testing to overcome underspecification
…, LH Schwartz, FZ Mokrane, L Dercle - Radiology: Artificial …, 2021 - pubs.rsna.org
The clinical deployment of artificial intelligence (AI) applications in medical imaging is perhaps
the greatest challenge facing radiology in the next decade. One of the main obstacles to …
the greatest challenge facing radiology in the next decade. One of the main obstacles to …
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules
Purpose To enhance clinician’s decision-making by diagnosing hepatocellular carcinoma (HCC)
in cirrhotic patients with indeterminate liver nodules using quantitative imaging features …
in cirrhotic patients with indeterminate liver nodules using quantitative imaging features …
[HTML][HTML] Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners
Objectives To identify an imaging signature predicting local recurrence for locally advanced
cervical cancer (LACC) treated by chemoradiation and brachytherapy from baseline 18 F-…
cervical cancer (LACC) treated by chemoradiation and brachytherapy from baseline 18 F-…
[HTML][HTML] Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory …
Purpose The goal of this guideline/procedure standard is to assist nuclear medicine
physicians, other nuclear medicine professionals, oncologists or other medical specialists for …
physicians, other nuclear medicine professionals, oncologists or other medical specialists for …
18F-FDG PET and CT scans detect new imaging patterns of response and progression in patients with Hodgkin lymphoma treated by anti–programmed death 1 …
The response evaluation criteria in patients with Hodgkin lymphoma (HL) were designed for
the assessment of chemotherapy and targeted molecular agents. We investigated the …
the assessment of chemotherapy and targeted molecular agents. We investigated the …
Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
Purpose We aimed to evaluate if imaging biomarkers on FDG PET are associated with
clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with …
clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with …